[1] |
Wieland AC, Mettler P, McDermott MT, et al. Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk[J]. J Clin Gastroenterol, 2015, 49(1): e6-e10.
|
[2] |
Ogawa Y, Imajo K, Yoneda M, et al.Pathophysiology of NAsh/NAFLD associated with high levels of serum triglycerides[J]. Nihon Rinsho, 2013, 71(9): 1623-1629.
|
[3] |
Glatz JF, Luiken JJ, Bonen A.Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease[J]. Physiol Rev, 2010, 90(1): 367-417.
|
[4] |
Miele L, Valenza V, La Torre G, et al.Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease[J]. Hepatology, 2009, 49(6): 1877-1887.
|
[5] |
Park EJ, Thomson AB, Clandinin MT.Protection of intestinal occludin tight junction protein by dietary gangliosides in lipopolysaccharide-induced acute inflammation[J]. J Pediatr Gastroenterol Nutr, 2010, 50(3): 321-328.
|
[6] |
Reid AE.Nonalcoholic steatohepatitis[J]. Gastroenterology, 2001, 121(3): 710-723.
|
[7] |
陈宗懋, 甄永苏. 茶叶的保健功能 [M]. 北京: 科学出版社, 2014.
|
[8] |
Dulloo AG, Duret C, Rohrer D, et al.Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans[J]. Am J Clin Nutr, 1999, 70(6): 1040-1045.
|
[9] |
Chen ZM, Lin Z.Tea and human health: biomedical functions of tea active components and current issues[J]. J Zhejiang Univ Sci B, 2015, 16(2): 87-102.
|
[10] |
Cao ZH, Gu DH, Lin QY, et al.Effect of pu-erh tea on body fat and lipid profiles in rats with diet-induced obesity[J]. Phytother Res, 2011, 25(2): 234-238.
|
[11] |
Hou Y, Shao W, Xiao R, et al.Pu-erh tea aqueous extracts lower atherosclerotic risk factors in a rat hyperlipidemia model[J]. Exp Gerontol, 2009, 44(6/7): 434-439.
|
[12] |
Lee LK, Foo K Y.Recent advances on the beneficial use and health implications of Pu-Erh tea[J]. Food Research International, 2013, 53: 619-628.
|
[13] |
Kuo KL, Weng MS, Chiang CT, et al.Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats[J]. J Agric Food Chem, 2005, 53(2): 480-489.
|
[14] |
肖凯, 朱晟易, 童钰铃. 普洱茶水提取物对大鼠非酒精性脂肪性肝病的干预作用[J]. 第三军医大学学报, 2013: 35(18): 1992-1995.
|
[15] |
Han X, Fink MP, Yang R, et al.Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice[J]. Shock, 2004, 21(3): 261-270.
|
[16] |
Harhaj NS, Antonetti DA.Regulation of tight junctions and loss of barrier function in pathophysiology[J]. Int J Biochem Cell Biol, 2004, 36(7): 1206-1237.
|
[17] |
许腊梅,孙丹莉,张予蜀. 紧密连接蛋白Occludin在非酒精性脂肪肝大鼠肠上皮细胞中的表达及其与TNF-α的关系[J]. 世界华人消化杂志, 2010, 18(10): 981-986.
|
[18] |
Fanning AS, Jameson BJ, Jesaitis LA, et al.The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton[J]. J Biol Chem, 1998, 273(45): 29745-29753.
|
[19] |
Liang Y, Zhang L.A study on chemical estimation of pu-erh tea quality[J]. Journal of the science of food agriculture, 2005, 95: 286-292.
|
[20] |
Zhou ZH, Zhang YJ, Xu M, et al.Puerins A and B, two new 8-C substituted flavan-3-ols from Pu-er tea[J]. J Agric Food Chem, 2005, 53(22): 8614-8617.
|
[21] |
Yang DJ, Hwang LS.Study on the conversion of three natural statins from lactone forms to their corresponding hydroxy acid forms and their determination in Pu-Erh tea[J]. J Chromatogr A, 2006, 1119(1/2): 277-284.
|
[22] |
吕海鹏, 林智, 谷记平, 等. 普洱茶中的没食子酸研究[J]. 茶叶科学, 2007, 27(2): 104-110.
|
[23] |
Lv H, Zhu Y, Tan J, et al.Bioactive compounds from Pu-erh tea with therapy for hyperlipidaemia[J]. Journal of Functional Foods, 2015, 19: 194-203.
|
[24] |
吕海鹏, 谷记平, 林智, 等. 普洱茶的化学成分及生物活性研究进展[J]. 茶叶科学, 2007, 27(1): 8-18.
|
[25] |
东方, 杨子银, 何普明, 等. 普洱茶抗氧化活性成分的LC-MS分析[J]. 中国食品学报, 2008, 8(2):133-141.
|